Blau Farmacêutica Dividends and Buybacks
Dividend criteria checks 2/6
Blau Farmacêutica is a dividend paying company with a current yield of 2.59% that is well covered by earnings. Next payment date is on 31st December, 2025 with an ex-dividend date of 24th March, 2025.
Key information
2.6%
Dividend yield
0%
Buyback Yield
| Total Shareholder Yield | 2.6% |
| Future Dividend Yield | 4.7% |
| Dividend Growth | 20.2% |
| Next dividend pay date | 31 Dec 25 |
| Ex dividend date | 24 Mar 25 |
| Dividend per share | n/a |
| Payout ratio | 38% |
Recent dividend and buyback updates
Recent updates
Latin America Expansion And R&D Will Unlock New Markets
Strategic LatAm expansion and international partnerships are set to boost revenue and expand market share across multiple countries.Blau Farmacêutica (BVMF:BLAU3) Has A Pretty Healthy Balance Sheet
Mar 21
Does Blau Farmacêutica (BVMF:BLAU3) Have A Healthy Balance Sheet?
Dec 04Results: Blau Farmacêutica S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 07Blau Farmacêutica S.A.'s (BVMF:BLAU3) 25% Share Price Surge Not Quite Adding Up
Nov 06Blau Farmacêutica S.A.'s (BVMF:BLAU3) 31% Price Boost Is Out Of Tune With Earnings
Aug 29Is Blau Farmacêutica (BVMF:BLAU3) A Risky Investment?
Jun 28Lacklustre Performance Is Driving Blau Farmacêutica S.A.'s (BVMF:BLAU3) 26% Price Drop
Feb 01What Does The Future Hold For Blau Farmacêutica S.A. (BVMF:BLAU3)? These Analysts Have Been Cutting Their Estimates
May 14Blau Farmacêutica S.A. Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next
Feb 24Getting In Cheap On Blau Farmacêutica S.A. (BVMF:BLAU3) Is Unlikely
Oct 14Robust Earnings May Not Tell The Whole Story For Blau Farmacêutica (BVMF:BLAU3)
Aug 17Stability and Growth of Payments
Fetching dividends data
Stable Dividend: BLAU3 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: BLAU3 has only been paying a dividend for 3 years, and since then payments have fallen.
Dividend Yield vs Market
| Blau Farmacêutica Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (BLAU3) | 2.6% |
| Market Bottom 25% (BR) | 2.9% |
| Market Top 25% (BR) | 9.3% |
| Industry Average (Biotechs) | 2.2% |
| Analyst forecast (BLAU3) (up to 3 years) | 4.7% |
Notable Dividend: BLAU3's dividend (2.59%) isn’t notable compared to the bottom 25% of dividend payers in the BR market (2.88%).
High Dividend: BLAU3's dividend (2.59%) is low compared to the top 25% of dividend payers in the BR market (9.25%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (38.1%), BLAU3's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (39.9%), BLAU3's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/22 20:18 |
| End of Day Share Price | 2025/05/21 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Blau Farmacêutica S.A. is covered by 11 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Marcio Osako | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |
| Frederico Mendes | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |
| Samuel Campos Alves | BTG Pactual |